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Clostridium perfringens is an opportunistic pathogen that can cause food poisoning
in humans and various enterotoxemia in animal species. Very little is known on the
bioﬁlm of C. perfringens and its exposure to subminimal inhibitory concentrations of
antimicrobials. This study was undertaken to address these issues. Most of the C.
perfringens human and animal isolates tested in this study were able to form bioﬁlm
(230/277). Porcine clinical isolates formed signiﬁcantly more bioﬁlm than the porcine
commensal isolates. A subgroup of clinical and commensal C. perfringens isolates was
randomly selected for further characterization. Bioﬁlm was found to protect C. perfringens
bacterial cells from exposure to high concentrations of tested antimicrobials. Exposure
to low doses of some of these antimicrobials tended to lead to a diminution of the
bioﬁlm formed. However, a few isolates showed an increase in bioﬁlm formation when
exposed to low doses of tylosin, bacitracin, virginiamycin, and monensin. Six isolates
were randomly selected for bioﬁlm analysis using scanning laser confocal microscopy.
Of those, four produced more bioﬁlm in presence of low doses of bacitracin whereas
bioﬁlms formed without bacitracin were thinner and less elevated. An increase in the area
occupied by bacteria in the bioﬁlm following exposure to low doses of bacitracin was
also observed in the majority of isolates. Morphology examination revealed ﬂat bioﬁlms
with the exception of one isolate that demonstrated a mushroom-like bioﬁlm. Matrix
composition analysis showed the presence of proteins, beta-1,4 linked polysaccharides
and extracellular DNA, but no poly-beta-1,6-N -acetyl-D-glucosamine.This study brings new
information on the bioﬁlm produced by C. perfringens and its exposure to low doses of
antimicrobials.
Keywords: Clostridium perfringens, biofilm formation, antibiotic prophylaxis, anticoccidials, biofilms, anaerobes,
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INTRODUCTION
The predominant organizational state of bacteria in nature is
bioﬁlms. They have been deﬁned as a structured commu-
nity of bacterial cells enclosed in a self-produced extracellular
matrix composed primarily of exopolysaccharides (Costerton
et al., 1999). The process of bioﬁlm formation involves the fol-
lowing stages: attachment, maturation and dispersion (Davey and
O’Toole, 2000; Hall-Stoodley and Stoodley, 2009). Features of cells
in bioﬁlms include: aggregation in suspension or on solid sur-
faces, increased antibiotic resistance, protection fromphagocytosis
and immune cells, and resistance to physical and environmental
stresses (Davey andO’Toole,2000;Davies,2003;Hall-Stoodley and
Stoodley, 2009). In Pseudomonas aeruginosa, extracellular DNA
present in the matrix was shown to chelate cations and to induce
the expression of antibiotic resistance (Mulcahy et al., 2008). Also,
promotion of bioﬁlm formation was observed through the abil-
ity of extracellular DNA to chelate Mg2+ (Mulcahy and Lewenza,
2011). Recently, current knowledge of bacterial bioﬁlms in animal
pathogens was reviewed (Jacques et al., 2010) and surprisingly,
very little is known about the bioﬁlm formed by Clostridium
perfringens.
Clostridiumperfringens is aGram-positive anaerobic bacterium
that causes numerous human and animal diseases, primarily as a
result of its ability to produce many different toxins (Markey et al.,
2013). A classiﬁcation based on the production of four major tox-
ins (alpha, beta, epsilon, and iota) divides the C. perfringens into
ﬁve toxigenic biotypes (A to E; Petit et al., 1999). C. perfringens has
been ranked by the Center for Disease Control and Prevention as
one of the most common bacterial causes of food-borne illness in
the United States, causing nearly a million cases each year, and is
also classiﬁed as a class-B bioterrorism agent (Scallan et al., 2011).
Recently, an increasing number of reports have implicated the
organism in antibiotic–associated diarrhea and sporadic diarrhea
cases inhumans, aswell as diarrhea cases in animals (Smedley et al.,
2004; Uzal et al., 2012; Banaszkiewicz et al., 2013). In chickens and
swine,C. perfringens causes enteritis, a disease of economic impor-
tance to the worldwide animal-food producing industry in terms
of both animal loss and vaccination costs (Markey et al., 2013). Iso-
lates of animal origin constitute a risk for transmission to humans
through the food chain. Recent studies have shown early signs
of acquired antibiotic resistance in C. perfringens indicating that
antibiotic resistance is now emerging (Lyras et al., 2009; Soge et al.,
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2009; Slavic´ et al., 2011; Charlebois et al., 2012). C. perfringens has
been the subject of considerable investigations in the past several
years; however, an area of substantial uncertainty relates to bioﬁlm
formationwith, orwithout exposure to low-doses of anticoccidials
and antibiotics. Anticoccidials are ionophores such as monensin,
narasin, and salinomycin that are used to prevent/treat infections
caused by coccidia, an obligate intracellular parasite, and in some
cases for their effect against C. perfringens. These compounds are
also used as growth promoters in some countries (Callaway et al.,
2003; Lefebvre et al., 2006; Diarra et al., 2007).
Only a few studies have reported on C. perfringens bioﬁlm
formation (Varga et al., 2008; Donelli et al., 2012). Type IV pilus
(TFP)-dependent gliding motility and the catabolite control pro-
tein (CcpA), a key regulator of the response to carbohydrate
limitation, were both shown to be necessary for efﬁcient bioﬁlm
formation (Varga et al., 2008). In the same study, the authors also
observed that bioﬁlm cells demonstrated 5- to 15-fold-increased
survival rate over planktonic cells after exposure to penicillin G
and an increased survival to oxygen stresses. It is suspected that
bioﬁlms of C. perfringens may play an important role in resis-
tance to environmental stresses (Varga et al., 2008). In a study
by Ledder et al. (2008) on coaggregation among numerically and
ecologically important intestinal bacteria, and between intestinal
bacteria and oral isolates, C. perfringens scored the highest over-
all for coaggregation among the gut species tested (Ledder et al.,
2008). To our knowledge, no other data is available on bioﬁlms of
C. perfringens.
Studies demonstrating that low-doses of antibiotics induce bac-
terial bioﬁlm formation have recently been reviewed by Kaplan
(Kaplan, 2011). In contrast, low dose of a ﬂuoroquinolone caused
a signiﬁcant decrease in adhesion and bioﬁlm formation by
Stenotrophomonas maltophilia (Pompilio et al., 2010). Also, lower
cell densities within bioﬁlms have been reported with sub-MIC of
dicloxicillin, a β-lactam antibiotic, for Staphylococcus epidermidis
and Staphylococcus haemolyticus (Cerca et al., 2005). The effect of
sub-MIC of bacitracin, virginiamycin, lincomycin, tylosin, and
ionophores on bioﬁlm formation has not yet been described in
C. perfringens. These antibiotics and ionophores are largely used in
swine and poultry production for therapy, prophylaxis purposes,
or as feed additives (low-dose usage) in some countries.
The aims of this study were to evaluate the bioﬁlm formation
of ﬁeld isolates of C. perfringens of various sources, to determine
bioﬁlm tolerance to oxygen and antibiotics, and to investigate
the effect of low doses of antibiotics and ionophores on bioﬁlm
formation.
MATERIALS AND METHODS
BACTERIAL ISOLATES
Commensal isolates of C. perfringens from poultry and swine were
recovered from the normal intestinal microbiota of animals taken
at seven (ﬁve poultry and two swine) processing plants located
in the province of Québec, Canada. Isolates were identiﬁed and
typed by PCR as previously described (Charlebois et al., 2012).
Clinical isolates of animal origin were provided by the Clinical
Laboratory of MolecularDiagnostic of Université deMontréal (St-
Hyacinthe, QC, Canada) and human isolates were provided by the
Infectious Disease Research Center of Université Laval (Québec,
Canada). Thawed isolates were grown on Columbia agar with 5%
sheep blood (Oxoid, Nepean, ON, Canada) and then incubated in
anaerobic condition at 37◦C.
BIOFILM GROWTH AND QUANTIFICATION
Different temperatures, incubation times and growth media with
and without glucose, as well as three different isolates (ATCC
13124, c1261A, FMV-CP12) were used to standardize the bioﬁlm
formation assay. More speciﬁcally, overnight blood agar cultures
of C. perfringens were resuspended at a density of 0.5 MacFarland
in Trypticase-peptone-glucose (TPG), ﬂuid thioglycolate (FTG),
tryptic soy broth (TSB; BD, Mississauga, ON, Canada) supple-
mented or not with 10 mM of ﬁlter-sterilized glucose (Sigma,
Oakville, ON, Canada), or Brain Heart Infusion (BHI) supple-
mented or not with 10 mM of ﬁlter-sterilized glucose. 100 μL of
cultures were added in 96-well polystyrene tissue culture plates
(Costar® #3595, Corning Incorporated, Corning, NY, USA) which
were then incubated anaerobically at 30, 35, or 44◦C for 1, 3,
or 6 days in a sealed container. All isolates recovered in this
study were tested for bioﬁlm formation. These experiments were
done in triplicate and repeated three times. Optimized bioﬁlm
growth conditions were as follows: bacterial cells were inoculated
in TSB medium supplemented with 10 mM of ﬁlter-sterilized
glucose and plates were incubated for 6 days at 44◦C in an
anaerobic environment. To quantify the bioﬁlm formation, the
crystal violet assay was used as described elsewhere (Varga et al.,
2008). C. perfringens ATCC 13124 was used as positive con-
trol because this strain was previously shown to produce bioﬁlm
(Varga et al., 2008).
Isolates were categorized as described previously (Stepanovic
et al., 2007). Brieﬂy, isolates were divided into the following cat-
egories: no bioﬁlm producer, weak bioﬁlm producer, moderate
bioﬁlm producer and strong bioﬁlm producer, based upon the
previously calculated optical density (OD) values measured at
570 nm: OD ≤ ODc = no bioﬁlm producer; ODc < OD ≤ 2×
ODc=weak bioﬁlm producer; 2×ODc<OD≤ 4×ODc=mod-
erate bioﬁlm producer; 4× ODc<OD = strong bioﬁlm producer.
ODc is deﬁned as three standard deviations (SD) above the mean
OD of the negative control. Isolates were also compared in regards
to a few parameters: clinical or commensal and animal sources. A
subgroup of C. perfringens isolates (n = 18) was randomly selected
for further characterization (Table 1). These were from the col-
lection of isolates recovered in this study from seven processing
plants. To those was added C. perfringens ATCC 13124 as a positive
control.
ANTIMICROBIAL SUSCEPTIBILITY TESTING
The subset of isolates was tested for MICs as previously described
in the CLSI M11-A8 document (CLSI, 2012). Brieﬂy, colonies
of C. perfringens, from a 24 h culture grown at 37◦C on blood
agar plates (Oxoid) under anaerobic conditions, were resuspended
into 5 mL of saline to achieve a 0.5 McFarland turbidity. This
adjusted inoculumwas then diluted 1:75 in supplemented Brucella
broth. 50 μL of this suspension was then transferred to individual
wells on microplates containing antibiotics. The microplates were
sealed and incubated in an anaerobic chamber for 48 h at 37◦C.
Antimicrobials tested were penicillin, lincomycin, virginiamycin,
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tylosin, salinomycin, narasin, and monensin (all from Sigma).
For bacitracin susceptibility testing, the Etest technique was used
as described earlier (Charlebois et al., 2012). Isolates with MIC
higher than 256 μg/mL by Etest were tested with the microdilu-
tions broth technique to determine the exact MIC. C. perfringens
ATCC 13124 was used as a control. Breakpoint for penicillin
(2 μg/mL) is available from CLSI M11-A8. There is a previously
published breakpoint for bacitracin (16μg/mL) that is widely used
in the literature (Chalmers et al., 2008; Charlebois et al., 2012). No
other breakpoints are available for the antimicrobials tested in this
study.
BIOFILM TOLERANCE TO OXYGEN, ANTIBIOTICS AND ANTICOCCIDIALS
A subgroup of C. perfringens isolates (n = 18) was randomly
selected from the collection of isolates recovered in this study
from seven processing plants. These isolates were tested for their
tolerance to oxygen and antibiotics when grown as bioﬁlms.
Bioﬁlms were cultured in triplicates as described above and
the initial ATP levels were measured with the BacTiter Glo kit
(Promega, Madison, WI, USA) in accordance with the manufac-
turer’s instructions. After 6 days of incubation, the supernatants
were removed and replaced with TSB-glucose in the bioﬁlm
cultures. The supernatants of the bioﬁlm containing the plank-
tonic cells were centrifuged and resuspended in fresh TSB-glucose
medium. Planktonic cells were then transferred to fresh tissue cul-
ture plates. For both the bioﬁlm cultures and planktonic cells, the
antibiotic and oxygen tolerance assays were performed. Brieﬂy,
plates were incubated anaerobically at 44◦C with 1.5 mg/mL of
bacitracin, 20 μg/mL of penicillin, 512 μg/mL of lincomycin,
4 μg/mL of virginiamycin, 256 μg/mL of tylosin, 1 μg/mL of
narasin, 2 μg/mL of salinomycin, or 4 μg/mL of monensin (all
antimicrobials from Sigma) for 6 or 24 h. These concentrations
of antimicrobials correspond to two times the highest MIC found
among the isolates of the random group. The effects of differ-
ent combinations of anticoccidials and antibiotics (monensin,
narasin, or salinomycin with bacitracin, tylosin, or virginiamycin)
on pre-formed bioﬁlms were also analysed. For the oxygen tol-
erance assay, plates were incubated aerobically at 44◦C for 6 or
24 h. After the oxygen and antimicrobial treatments, the ATP
levels were measured with the BacTiter Glo kit. Percentages of
survival were calculated by dividing the ﬁnal ATP level by the ini-
tial ATP level. Treatment with penicillin was used as a positive
control. The effect of low doses of antibiotics and anticoccidials
on bioﬁlm formation was assessed on the randomly selected C.
perfringens isolates (n = 18). Brieﬂy, bioﬁlms were cultured as
described above with the exception that antibiotics were added at
a concentration of 0.1× the MICs of each isolate before incuba-
tion. All plates were incubated anaerobically at 44◦C for 6 days
in a sealed container. All isolates were done in triplicates. To
quantify the bioﬁlm formation, the crystal violet assay was used
as described above. Control wells were incubated with medium
only.
EFFECTS OF ENZYMATIC TREATMENTS ON BIOFILM FORMATION
Bioﬁlms of the selected C. perfringens isolates (n = 18) were
grown for 6 days in TSB supplemented with 10 mM of glucose
as described above. Wells were washed 2x with distilled water and
then ﬁlled with 100 μL of PBS containing 20 μg/mL of dispersin B
(Kane Biotech Inc.,Winnipeg, MB, Canada) as described by Izano
et al. (2007), or 100 μg/mL of DNase I or proteinase K (Kaplan
et al., 2004; Grasteau et al., 2011). Plates were incubated at 37◦C for
5 min for the dispersin B or 1 h for the DNase I and the proteinase
K. For the cellulase treatment, wells were ﬁlled with 120 U/mL of
cellulase and then incubated at 45◦C for 72 h (Jain and Bhosle,
2008). After incubation, wells were washed once with distilled
water and stained with crystal violet. Staphylococcus aureus ATCC
25923 was used as a positive control for all treatments.
SCANNING LASER CONFOCAL MICROSCOPY
Bioﬁlms of the selected C. perfringens isolates (n = 18) were grown
in 96-well plates as described above with or without low doses of
bacitracin. Plates were incubated for 6 days at 44◦C under anaer-
obic conditions. After incubation, wells were washed two times
with PBS to remove unattached cells. 100 μL of PBS contain-
ing the ﬂuorescent FM 1-43 stain (Invitrogen, Burlington, ON,
Canada), was added to each well to allow visualization of individ-
ual bacteria by laser confocal microscopy. In addition, 50 μg/mL
of calcoﬂuor white dye (Sigma), which is speciﬁc for beta-1,3 and
beta-1,4 linkages in polysaccharides, was added to each well. This
stain was selected because it was previously shown to bind to
C. perfringens bioﬁlm matrix (Varga et al., 2008). After incuba-
tion at room temperature for 30 and 15 min, respectively, wells
were washed with 200 μL of sterile distilled water. Before read-
ings, 100 μL of sterile distilled water was added to each well. An
Olympus FV1000 IX81 laser confocal microscope was used to col-
lect three-dimensional images of the bioﬁlms. An argon laser set
at 472 nm was used to excite the FM 1-43 dye (emission green)
and a UV laser at 364 nm to excite the calcoﬂuor white dye (emis-
sion blue). The images were processed using Fluoview software
(Olympus). For the matrix composition, the bioﬁlms were cul-
tured as described above. The ﬂuorophores assay was done as
described previously (Wu et al., 2013a). Brieﬂy, after the incuba-
tion, the wells were ﬁlled with 100 μL of Wheat Germ Agglutinin
(WGA) – Oregon Green 488, Sypro Ruby Red or BOBO-3 (all
from Invitrogen). WGA was diluted 1/100 in PBS whereas BOBO-
3 was diluted 1/1500 in water. Sypro Ruby Red was used as
described by the manufacturer. Plates were incubated for 30 min
at room temperature in the dark then washed once with water
and ﬁlled with 100 μL PBS. The plates were observed by con-
focal microscopy. The excitation/emission wavelengths for the
ﬂuorophores were as follow: 496/524 nm (WGA), 450/610 nm
(Sypro Ruby Red), and 570/602 nm (BOBO-3). The images
were processed using Fluoview software (Olympus). Staphylo-
coccus aureus ATCC 25923 was used as a positive control for all
ﬂuorophores.
STATISTICAL ANALYSIS
The statistical signiﬁcance (p value) of differences in bioﬁlm
between the animal origin or commensal and clinical isolates were
calculated with an unequal variance linear model. A Student t-
test was used for the bioﬁlm tolerance to oxygen and antibiotics
assays, the low-dose and the enzymatic treatments. A p < 0.05
was considered to be signiﬁcant. Statistics were done with the SAS
software v.9.1. (Cary, NC, USA).
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RESULTS
BACTERIAL ISOLATES
A total of 277 C. perfringens isolates of poultry (clinical, n = 14;
commensal, n= 136), swine (clinical, n= 34; commensal, n= 50),
human (clinical, n = 9), and other animal origins [clinical isolates
from cows (n = 12), sheep (n = 10), goats (n = 3), horses (n = 3),
deer (n = 1), duck (n = 1), alpaca (n = 1), cat (n = 1), dog
(n = 1), and hare (n = 1)] were isolated for this study. A total of
273 isolates were of type A and 4 of type D. Type D isolates were
found in clinical samples from bovine (n = 1) and ovine (n = 3).
BIOFILM GROWTH AND QUANTIFICATION
Most of the C. perfringens isolates tested were able to form bioﬁlm
(n = 230/277) in the conditions used in this study. The OD val-
ues at 570 nm (OD570) ranged from 0.009 to 0.489 (Figure 1)
indicating that bioﬁlm formation can vary among tested iso-
lates. Of those, strong (n = 7), moderate (n = 42), and weak
(n = 181) bioﬁlm producers were observed. Bioﬁlm forma-
tion was compared among clinical and commensal isolates of
C. perfringens of animal origin to test whether there is a dif-
ference between these two groups of isolates. The mean OD
value of bioﬁlm formed by clinical isolates originating from
swine was signiﬁcantly higher (p < 0.05) than the mean OD
value of their commensal counterparts (Figure 1). However, no
difference in bioﬁlm formation was observed between clinical
and commensal isolates of poultry origin (p > 0.05). The low
number of clinical poultry isolates was likely not sufﬁcient to
allow a statistical signiﬁcance to be seen. Also, bioﬁlm forma-
tion was compared among isolates of C. perfringens of different
animal origins. No signiﬁcant difference in bioﬁlm formation
was observed between isolates recovered from swine, poultry,
human, and other animal origins (p > 0.05). Again, the low
number of human and other animal species isolates was likely
not sufﬁcient to allow a statistical signiﬁcance to be seen. A
FIGURE 1 | Biofilm formation by C. perfringens isolates. Bioﬁlm
formation of C. perfringens strains in 96-well plates, measured after 6 days
as described in Section “Materials and Methods.” The p values were
calculated using a linear model for unequal variances. Each dot represents
the mean of the replicates for each strain. The bars represent the mean
values of each group.
subgroup of C. perfringens isolates (n = 18) were randomly
selected for further characterization (Table 1). These were from
the collection of isolates recovered in this study from seven pro-
cessing plants. To those, we included the C. perfringens ATCC
13124. The following categories were covered in this subgroup:
commensal, clinical, swine, poultry, human, and different lev-
els of bioﬁlm productions. However, C. perfringens isolates of
other animal species from this study are not represented in this
subgroup.
ANTIMICROBIAL SUSCEPTIBILITY TESTING
Isolates tested (n = 19) demonstrated low MICs to penicillin
(0.002–0.12 μg/mL), virginiamycin (0.12–2 μg/mL), narasin
(0.03–0.25 μg/mL), salinomycin (0.015–1 μg/mL), and monensin
(0.015–2 μg/mL; Table 1). For bacitracin, 13 isolates were sus-
ceptible (0.75–16 μg/mL) and 5 were resistant (256–512 μg/mL).
For lincomycin, MICs between 0.5 and 512 μg/mL were observed
whereas for tylosin, MICs between 0.5 and 128 μg/mL were
obtained.
BIOFILM TOLERANCE TO OXYGEN, ANTIBIOTICS AND ANTICOCCIDIALS
In the atmospheric oxygen tolerance assays, the mean viability
rates of planktonic cells after exposure to oxygen for 6 and 24 h
were 63 and 7.4%, respectively (Figure 2A). However, the viability
rates were higher (80.6% of viable cells after 6 h and 61% after
24 h) when C. perfringens cells were organized in bioﬁlm. Data
between planktonic cells and bioﬁlm, obtained after an incuba-
tion of 24 h, were signiﬁcantly different (p < 0.05) (Figure 2A).
For the antibiotic and anticoccidials tolerance assays, planktonic
cells had between 7.0 and 69.1% of viability after 6 h exposure and
between 1.2 and 20.7% of viability after 24 h exposure to antibi-
otics or anticoccidials. On the other hand, cells in bioﬁlm had
between 32.7 and 65.0% of viability, and between 14.3 and 47.1%
of viability for the same periods of time, corresponding to a 0.6-
to 9-fold-increased survival rate after 6 h and to a 0.8- to 36-fold-
increased survival rate after 24 h over planktonic cells. Viability
rates for cells in bioﬁlm were signiﬁcantly higher (p < 0.05) than
those observed for planktonic cells (Figures 2B–I). Antibiotics
and anticoccidials were also used in combination to determine
if there was a synergistic activity toward cells of C. perfringens
ATCC 13124 within a bioﬁlm (Table 2). A higher activity was
observed for six combinations but these resultswere not signiﬁcant
(p > 0.05).
BACTERIAL EXPOSURE TO LOW DOSES OF ANTIBIOTICS AND
ANTICOCCIDIALS
After exposure of isolates (n = 19) to low doses of antibiotics and
anticoccidials, no clear trend was observed for bacitracin, tylosin,
virginiamycin, and monensin (Figures 3A,B,D,H) but a few iso-
lates showed an increase in bioﬁlm formation when exposed to
those compounds. However, exposure to low doses of penicillin,
lincomycin, salinomycin, and narasin tended to lead to a diminu-
tion of the bioﬁlm formed (Figures 3C,E,F,G). This phenomenon
was particularly observed within the poultry clinical group of iso-
lates. No other trends could be observed. Statistically signiﬁcant
results are indicated in Figure 3 (p < 0.05).
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FIGURE 2 |Viability of planktonic cells compared to cells in biofilm
following exposure to oxygen and antimicrobials. C. perfringens
6-days-old bioﬁlms and planktonic cultures were exposed to (A) atmospheric
oxygen, (B) 1.5 mg/mL of bacitracin, (C) 20 μg/mL of penicillin, (D) 512 μg/mL
of lincomycin, (E) 4 μg/mL of virginiamycin, (F) 256 μg/mL of tylosin, (G)
4 μg/mL of monensin, (H) 2 μg/mL of salinomycin, or (I) 1 μg/mL of narasin
for the times indicated. Differences in survival of planktonic cells [P] versus
bioﬁlm [B] at each time were compared using Student’s t -test. *p < 0.05.
The error bars represent standard deviations. Results presented are for strain
C. perfringens ATCC 13124. For all isolates, statistically signiﬁcant increases
in viabilities were observed for bacteria in bioﬁlms compared to planktonic
cells.
SCANNING LASER CONFOCAL MICROSCOPY
Using laser confocalmicroscopy, bioﬁlmsof tested isolates (n=19)
were stainedwith the ﬂuorescent dyes SYPRORubyRed,WGAand
BOBO-3 in order to visualize extracellular proteins, poly-beta-1,6-
N-acetyl-D-glucosamine (PNAG) exopolysaccharide and DNA,
respectively. Extracellular proteins and DNA were visible in
bioﬁlms of all tested isolates (Figure 4). However, PNAG was
absent from the bioﬁlm formed by C. perfringens isolates. Binding
of calcoﬂuor white to the bioﬁlm matrix was observed. Cal-
coﬂuor white binds to polysaccharides with beta-1,3 and beta-1,4
Table 2 |Viability (%) of C. perfringens strain ATCC 13124 in biofilm
after 24 h incubation with antibiotics and anticoccidials alone or in
combinations.
Alone Monensin Salinomycin Narasin
Alone 100 65.5 79.5 61.8
Bacitracin 74.2 74.4 67.4 59.0
Virginiamycin 70.5 62.9 58.4 72.1
Tylosin 69.1 77.8 55.9 59.8
Values underlined: values of the combination lower than the antimicrobials used
alone.
linkages. Six isolates (C. perfringens c1261_A, c3807_A, ATCC
13124, SHY07-383, FMV-CP23 and c3437_A) were randomly
selected to further analyse their bioﬁlms in the presence of low
dose of bacitracin (0.3 × MIC). The bioﬁlms of these iso-
lates grown in the presence of bacitracin were approximately
between 35 and 80 μm in height, whereas bioﬁlms formed
without bacitracin were thinner with elevations between 30 and
60 μm (Table 3). It was also found that ﬁve of them showed an
increase in the area occupied by bacteria in the bioﬁlm follow-
ing exposure to low doses of bacitracin (Table 3). Laser confocal
microscopy images showed that the bioﬁlm formed by the C. per-
fringens isolates (n = 6) were mainly ﬂat (Figure 5A) with the
exception of one isolate demonstrating a mushroom-like bioﬁlm
(Figure 5B).
ENZYMATIC TREATMENTS ON BIOFILM FORMATION
Dispersion of the bioﬁlm matrix of C. perfringens iso-
lates (n = 19) was not observed with dispersin B enzy-
matic treatment conﬁrming that PNAG is absent from
the matrix formed by the tested C. perfringens isolates.
However, proteinase K, cellulase, and DNase I enzy-
matic treatments signiﬁcantly dispersed the preformed bioﬁlm
(p < 0.05) indicating the presence of proteins, beta-1,4
linked polysaccharides and extracellular DNA in the matrix
(Figure 6).
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FIGURE 3 | Effect of low-dose antimicrobials on biofilm formation.
Bioﬁlm formation of C. perfringens strains in 96-well plates in presence of
0.1× MIC of bacitracin (A), tylosin (B), penicillin (C), virginiamycin (D),
lincomycin (E), salinomycin (F), narasin (G), or monensin (H), measured as
described in Section “Materials and Methods.” Strains are in the following
order: c1261_A, c2188_B, c3336_B, c3342_A, c3342_B, c3437_A, c3807_A,
ATCC 13124, CCRI-16276, FMV-CP4, FMV-CP23, FMV-CP71, 1285414,
1304504, SHY07-383, STF2003-1256, 2006-4758, CP4, and JGS 4143.
Results are expressed as percentages of the control not exposed to
antibiotics. Conditions were compared to the control bioﬁlm using Student’s
t -test.*p < 0.05. The error bars represent standard deviation. Black bands
represent poultry clinical isolates.
FIGURE 4 | Matrix composition of C. perfringens biofilm. Representative
results of the matrix composition of C. perfringens bioﬁlm observed with
ﬂuorescent probes. Staphylococcus aureus ATCC 25923 was used as a
positive control for all ﬂuorophores. FM1-43: bacterial cells; BOBO-3:
extracellular DNA,WGA: PNAG; Ruby Red: proteins; Calcoﬂuor white:
beta-1,3 and beta-1,4 linked polysaccharides.
DISCUSSION
Most of the tested isolates in this study which originated from
various animal species were able to form bioﬁlm at various
degrees in the conditions used. Optimized bioﬁlm growth con-
ditions were different than those previously described (Varga
et al., 2008; Donelli et al., 2012). However, results of this study
are in accordance with the ones obtained by Varga et al. (2008)
where all sequenced strains of C. perfringens (biotypes A of
ATCC 13124, 13, and SM101), as well as representatives of
type C, D, and E strains which cause infections in animals were
shown to form bioﬁlms with OD values between 0.07 and 0.5
(Varga et al., 2008). Donelli et al. (2012) were able to obtain
a higher bioﬁlm formation for C. perfringens strain CpeBs31
in their study, with a mean OD of 3.2, which classiﬁed this
isolate as strongly adherent under the following conditions:
BHI supplemented with 1% glucose and 48 h incubation at
37◦C (Donelli et al., 2012). This strain was not tested in our
study.
In the present study, clinical isolates recovered from swine
formed signiﬁcantly more bioﬁlm than their commensal coun-
terparts. In Salmonella typhymurium, it was found that clinical,
outbreak-associated and retail product isolates produced thicker
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Table 3 | Effect of subinhibitory concentrations of bacitracin on biofilm
formation as analyzed by scanning laser confocal microscopy.
Isolates Total height
(μm)
Matrix
(μm)
Cells
(μm)
Increased
bioﬁlm
c1261_A 35 18 17
c1261_A + bacitracin 60 40 20
c3807_A 45 35 10
c3807_A + bacitracin 75 40 35
c3437_A 30 22 8
c3437_A + bacitracin 80 50 30
SHY07-383 50 25 25
SHY07-383 + bacitracin 55 20 35
Decreased
bioﬁlm
ATCC 13124 45 33 12
ATCC 13124 + bacitracin 40 23 17
FMV-CP23 60 35 25
FMV-CP23 + bacitracin 35 20 15
bioﬁlms compared to isolates recovered from food (Castelijn et al.,
2012). Reisner et al. (2006) did not observe an increased bioﬁlm
formation in human clinical strains of intestinal Escherichia coli.
Skyberg et al. (2007) also found that isolates of Escherichia coli
recovered from healthy birds produced signiﬁcantly stronger
bioﬁlms than isolates from cases of avian colibacillosis. In Lis-
teria monocytogenes, it was found that isolates from food formed
more bioﬁlm than clinical isolates recovered from cases of liste-
riosis (Barbosa et al., 2013). For C. perfringens, bioﬁlm formation
could play a role in the development of the disease because bioﬁlm
can help bacteria adhere to surfaces, and this facilitates coloniza-
tion and infection. Moreover, the ability to grow as a bioﬁlm favors
survival of bacteria in the environment (Semenyuk et al., 2014). In
this study, it was observed that clinical isolates of swine C. perfrin-
gens formed more bioﬁlms suggesting these isolates might survive
longer in the environment.
C. perfringens is known to be an aerotolerant bacterium capa-
ble of surviving in soil or water (Rood and Cole, 1991). Results
obtained with the atmospheric oxygen tolerance assays showed
that the bioﬁlm could protect C. perfringens cells from oxy-
gen stress. Varga et al. (2008) obtained similar results in their
study. The involvement of bioﬁlm in oxygen tolerance has already
been described in Fusobacterium nucleatum, another anaerobic
bacterium (Gursoy et al., 2010). The present study also showed
that the bioﬁlm could protect C. perfringens from high concen-
trations of antibiotics and anticoccidials. Increased survival of
C. perfringens cells in bioﬁlm following penicillin G exposure
have been described elsewhere (Varga et al., 2008). Interestingly,
virginiamycin, tylosin, and the three anticoccidials (namely mon-
ensin, narasin, and salinomycin) had good activity against cells
in bioﬁlm, decreasing the viability below 50%. Virginiamycin has
already been found to be active against bioﬁlms formed by some
strains of Lactobacillus spp. (Rich et al., 2011) but to our knowl-
edge, the effects of tylosin and anticoccidials on bioﬁlm have never
been described. Results could not be subdivided between bac-
tericidal and bacteriostatic antimicrobials because bacteriostatic
antimicrobials used at high concentrations likely become bacte-
ricidal (Pankey and Sabath, 2004). The reverse is also reported,
bactericidal agents used at low doses likely become bacteriostatic
(Pankey and Sabath, 2004). In the bioﬁlm tolerance assay, antimi-
crobials were used at high concentrations indicating that tylosin
and lincomycin are both likely acting as bactericidal in this exper-
iment. In the bacterial exposure to low doses of antimicrobials
assay, all antimicrobials likely became bacteriostatic due to the low
doses used in this experiment. Moreover, in the present study, dif-
ferent combinations of antibiotics and anticoccidials were assessed
for their activity against cells in bioﬁlm. In general, the viability
in the bioﬁlm tended to be lower when exposed to a combination
FIGURE 5 | Biofilm morphologies observed by scanning laser confocal microscopy. Bioﬁlms formed by the C. perfringens c3437_A isolate (A) or by the
C. perfringens SHY07-383 isolate (B) after 6 days of incubation. Blue: exopolysaccharides (Calcoﬂuor white); Green: bacteria (FM 1–43).
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FIGURE 6 | Effect of enzymatic treatments on pre-formed
C. perfringens biofilm. DNase, proteinase K, cellulase, and dispersin B
effects on pre-formed bioﬁlm of C. perfringens. Data were measured as
described in Section “Materials and Methods.” Results are the average of
all strains tested and are expressed as a percentage of the control. The
error bars represent standard deviation.*p < 0.05.
compared to either component used alone. Different combina-
tions of antibiotics have already been described to be active against
bioﬁlm of Staphylococcus epidermidis, methicillin-resistant and
-susceptible Staphylococcus aureus (MRSA and MSSA), P. aerug-
inosa, and Enterococcus faecalis (Saginur et al., 2006; Tre-Hardy
et al., 2008; Holmberg et al., 2012;Wu et al., 2013b). This tolerance
to antimicrobial agents observed in bioﬁlm makes the treatment
of these infections generally ineffective. For C. perfringens, it has
been hypothesized that bioﬁlm formation by this organism in the
small intestine could contribute to antibiotic-associated diarrhea,
a form of non-food-borne enteritis associated with antibiotic use,
by facilitating in bacterial persistence through antibiotic treatment
(Varga et al., 2008).
Because it has been described that low doses of antibiotics can
either reduce or increase the bioﬁlm production in other bacte-
ria (Cerca et al., 2005; Hoffman et al., 2005; Majtan et al., 2008;
Kaplan, 2011), the effect of low concentrations of antibiotics and
anticoccidials on C. perfringens bioﬁlm formation was studied by
microplates assays. No clear trend was observed when exposed
to low doses of antibiotics with the exception of penicillin, lin-
comycin, salinomycin, and narasin. In these cases, less bioﬁlm
was detected in the majority of isolates. Also, the effect of the
antibiotics and anticoccidials on the bioﬁlm varied depending on
the strain tested indicating that this phenomenon is strain depen-
dent. These variations among strains have also been observed for
Staphylococcus epidermidis exposed to 0.5× the MIC of cefazolin,
vancomycin, and dicloxacillin, and for Streptococcus pyogenes
exposed to 0.015× to 0.5× the MIC of ﬂuoroquinolones (Hen-
riques et al., 2005; Balaji et al., 2013). To further analyse the effect
of low doses of bacitracin on C. perfringens bioﬁlms, laser confocal
microscopy was used. An increase in the area occupied by bacte-
ria was observed in bioﬁlms exposed to low doses of bacitracin.
This increased area occupied by bacteria has also been observed in
Staphylococcus epidermidis bioﬁlms exposed to 0.25× the MIC of
erythromycin, in P. aeruginosa bioﬁlms exposed to 0.25X the MIC
of imipenem and in Streptococcus intermedius bioﬁlms exposed
to sub-MICs of ampicillin, ciproﬂoxacin, and tetracycline (Bagge
et al., 2004; Ahmed et al., 2009; Wang et al., 2010).
To analyse the structure of C. perfringens bioﬁlms, laser con-
focal microscopy was used and results obtained were consistent
with the ones found in the study of Varga et al. (2008). In this
study, most of the bioﬁlms analysed in confocal microscopy were
ﬂat with one exception that showed a mushroom-like structure.
To our knowledge, this is the ﬁrst description of a mushroom-
like bioﬁlm in C. perfringens. For the matrix, it was found that
the bioﬁlm of C. perfringens contained polysaccharides, proteins,
and extracellular DNA. Proteins and carbohydrates have already
been described as components of C. perfringens bioﬁlms (Varga
et al., 2008). In addition to polysaccharides and proteins, extra-
cellular DNA was also found to be a part of the matrix. The
presence of extracellular DNA in the matrix of the bioﬁlm has
been described in otherGrampositive bacteria (Barnes et al., 2012;
Domenech et al., 2012; Kaplan et al., 2012) but to our knowledge,
not in Clostridia. The mechanisms by which the DNA is released
in bioﬁlms are poorly understood but autolysis of cells has been
hypothesized to mediate DNA release (Bayles, 2007; Ma et al.,
2009). In Enterococcus faecalis, the release of extracellular DNA
by autolysis is regulated by the action of the two proteases GelE
and SprE (Thomas et al., 2008) whereas in Staphylococcus aureus, a
ﬁnely tuned holin/antiholin system is thought to mediate cell lysis
and programmed cell death (Bayles, 2007; Rice and Bayles, 2008).
A previous study has revealed no extracellular DNA in bioﬁlms
of both Bordetella bronchiseptica strain 276 and Escherichia coli
strain ECL 17602 using confocal laser scanning microscopy (Wu
et al., 2013a), indicating that extracellular DNA is not a compo-
nent of all bioﬁlms. The presence of PNAG in the bioﬁlm was
studied because it is one of the most common and extensively
studied matrix EPS (Jacques et al., 2010). In this study, PNAG was
absent from C. perfringens bioﬁlm matrix. This has been observed
in other bacteria (Wu et al., 2013a). Binding of calcoﬂuor white
to the bioﬁlm indicated that polysaccharides with beta-1,3 and
beta-1,4 linkages, such as cellulose, are part of the matrix. To con-
ﬁrm this hypothesis, bioﬁlms were treated with cellulase (Jain and
Bhosle, 2008). It was observed that this enzyme could disperse the
bioﬁlmof C. perfringens conﬁrming, for the ﬁrst time, the presence
of beta-1,4 linked polysaccharides in the matrix.
In conclusion, this study reports for the ﬁrst time the pres-
ence of extracellular DNA and beta-1,4 linked polysaccharides
in the matrix of C. perfringens bioﬁlms. This study also demon-
strated that virginiamycin, tylosin, and anticoccidials were active
against C. perfringens cells in bioﬁlm. Exposure to low doses of
penicillin, lincomycin, salinomycin, and narasin tended to lead
to a diminution of the bioﬁlm formation. Further studies are
needed to characterize the exopolysaccharides found in the matrix
and to identify the genes involved in the bioﬁlm formation in C.
perfringens.
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